Encompass Health Corporation Cash Provided by (Used in) Financing Activities, Discontinued Operations
Encompass Health Corporation (EHC) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2025-02-28
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for the quarter ending 2023-12-31 was $0.00.
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for the quarter ending 2023-09-30 was $0.00.
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for fiscal 2024 was $0.00.
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for fiscal 2022 was $515.10M.
- Encompass Health Corporation cash provided by (used in) financing activities, discontinued operations for fiscal 2021 was -$10.20M.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | -$1.00M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | -$1.00M derived: sum of 3 quarters · filed 2025-02-28 | -$54.70M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-03 | -$1.00M derived: sum of 2 quarters · filed 2025-02-28 | -$54.70M derived: sum of 3 quarters · filed 2025-02-28 | $510.00M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$54.70M derived: sum of 2 quarters · filed 2025-02-28 | $510.00M derived: sum of 3 quarters · filed 2025-02-28 | $515.10M 10-K · filed 2025-02-28 | |
| 2022-09-30 | -$53.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $511.00M derived: sum of 2 quarters · filed 2023-11-01 | $516.10M 10-Q · filed 2023-11-01 | $515.10M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $564.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $569.80M 10-Q · filed 2023-08-04 | $568.80M derived: sum of 3 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $5.10M 10-Q · filed 2023-05-03 | $4.10M derived: sum of 2 quarters · filed 2024-02-28 | |||
| 2021-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$10.20M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$9.20M 10-Q · filed 2022-11-02 | ||||
| 2020-12-31 | -$11.60M 10-K · filed 2023-02-27 | ||||
| 2011-12-31 | $0.00 8-K · filed 2012-09-06 | ||||
| 2010-12-31 | $100.00K derived: 8-K 12 month − 10-Q 9 month · filed 2012-09-06 | $0.00 derived: sum of 2 quarters · filed 2012-09-06 | $0.00 8-K · filed 2012-09-06 | ||
| 2010-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$100.00K 10-Q · filed 2011-11-04 | |||
| 2010-06-30 | $0.00 10-Q · filed 2010-08-05 | ||||
| 2009-12-31 | -$200.00K derived: 8-K 12 month − 10-Q 9 month · filed 2012-09-06 | -$600.00K derived: sum of 2 quarters · filed 2012-09-06 | $1.20M 8-K · filed 2012-09-06 | $1.30M 10-K · filed 2011-02-24 | |
| 2009-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | $1.40M 10-Q · filed 2010-11-03 | |||
| 2009-06-30 | $1.80M 10-Q · filed 2010-08-05 | ||||
| 2008-12-31 | -$3.80M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |